Ramosetron Versus Palonosetron in Combination With Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2019.713
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2020
Authors
Publisher
Korean Cancer Association